Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Biocoen** is a Chinese fixed-dose injectable compound-coenzyme product manufactured by Beijing SL Pharmaceutical. It is reported to contain coenzyme A and coenzyme I, also known as nicotinamide adenine dinucleotide, and is intended to support cellular energy metabolism rather than act through a single receptor or enzyme target. Preclinical rat studies evaluated its potential protective effects after cardiopulmonary resuscitation, while a registered Chinese clinical study evaluated perioperative administration for myocardial injury associated with lower-limb tourniquet-induced ischemia-reperfusion injury. ([xuebao.smmu.edu.cn](https://xuebao.smmu.edu.cn/ajsmmu/article/export/041105?action_type=export&export_type=xml&include_content=2))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound coenzyme.